brequinar has been researched along with flavin mononucleotide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clardy, J; Hurt, DE; Sutton, AE | 1 |
| Al-Karadaghi, S; Dahlberg, L; Dufe, VT; Fritzson, I; Khairoullina, A; Svensson, B; Walse, B; Wellmar, U | 1 |
2 other study(ies) available for brequinar and flavin mononucleotide
| Article | Year |
|---|---|
Brequinar derivatives and species-specific drug design for dihydroorotate dehydrogenase.
Topics: Animals; Biphenyl Compounds; Crystallography, X-Ray; Dihydroorotate Dehydrogenase; Drug Design; Enzyme Inhibitors; Flavin Mononucleotide; Humans; Hydrogen Bonding; Orotic Acid; Oxidoreductases Acting on CH-CH Group Donors; Plasmodium falciparum; Species Specificity | 2006 |
The structures of human dihydroorotate dehydrogenase with and without inhibitor reveal conformational flexibility in the inhibitor and substrate binding sites.
Topics: Binding Sites; Biphenyl Compounds; Carboxylic Acids; Crystallography, X-Ray; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Flavin Mononucleotide; Humans; Naphthalenes; Orotic Acid; ortho-Aminobenzoates; Oxidoreductases Acting on CH-CH Group Donors; Protein Binding; Protein Structure, Secondary; Recombinant Proteins; Ubiquinone | 2008 |